Healthcare Regulatory Deep Dive
A stats-rich infographic view of FDA market access, HIPAA data rules, reimbursement coding, and the commercialization gauntlet that shapes healthcare B2B sales.
3
FDA device classes: low, moderate, and high risk.
510(k)
Common FDA pathway for many Class II medical devices.
100%
PHI-touching vendors need security and privacy readiness.
4
Major commercialization gates before scalable adoption.
Regulatory Ecosystem
FDA Market Access
FDA regulates medical devices, drugs, and software-as-a-medical-device. Without proper clearance, selling legally becomes difficult.
HIPAA Data Access
HIPAA governs protected health information. Software touching patient data must address privacy, security, and business associate requirements.
Reimbursement Coding
CPT, DRG, and CMS reimbursement logic can determine whether providers can bill for a solution and justify purchase.
Functional Regulatory Charts
Compliance Impact Pie Chart
Commercialization Risk Score
The Commercialization Gauntlet
Concept & Funding
Innovation begins with prototype development and early funding.
Regulatory Clearance
FDA submission, clinical evidence, 510(k), or PMA pathways.
Reimbursement Coding
Securing CPT or DRG codes so providers can bill for the solution.
Market Access
GPO contracts, IDN value analysis committees, and IT security reviews.
Why This Matters for Sales
In healthcare B2B, you are not just selling features; you are selling compliance and reimbursement. If your team cannot speak FDA, HIPAA, and reimbursement language, gatekeepers can block the deal.
Intent Insight
High intent for “SOC2 Type II” or “HITRUST” from a health system can signal an active vendor displacement cycle.
Sell to the CISO Early
Do not wait until the end of the deal to address security.
Map the VAC Process
Know the value analysis committee schedule and review criteria.
Validate Reimbursement
Make sure CPT, DRG, or billing pathways are active and understood.